CLLS – cellectis s.a. - american depositary shares (US:NASDAQ)

News

Cellectis (NASDAQ:CLLS) was upgraded by analysts at Clear Str Llc to a "strong-buy" rating.
Cellectis Announces Arbitral Decision in Dispute with Servier [Yahoo! Finance]
Cellectis Announces Arbitral Decision in Dispute with Servier
ASH 2025: Cellectis Presents Development Plan to Further Enhance High Response Rate Observed for Eti-cel in r/r NHL
Cellectis Publishes Nature Communications Article on a Non-Viral Gene Editing Process Enabling Efficient Gene Insertion in Hematopoietic Stem Cells
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com